Korean biopharmaceutical companies are exploring opportunities at Bio Japan 2024 amid U.S.-China tensions, with major firms ...

WuXi AppTec looks to unload its Philadelphia manufacturing sites and WuXi Biologics slows its rapid expansion in the U.S. as ...

The current status of the Biosecure Act is that it was passed ​ by the US House of Representatives on Sep 9, with a vote of ...

Less frequent dosing could provide Eli Lilly’s Ebglyss room to rival Sanofi and Regeneron’s blockbuster Dupixent.

Bayer has entered a collaboration with MOMA Therapeutics in which the two companies will advance a small molecule oncology ...

CHINA’S WuXi AppTec will raise US$500 million in a convertible bond sale, according to a regulatory filing on Tuesday (Oct 8) ...

WuXi AppTec Co. is raising $500 million through the sale of convertible bonds, becoming the latest Chinese company to turn to ...

China's WuXi AppTec , will raise $500 million in a convertible bond sale, according to a regulatory filing on Tuesday, a ...

On 9 September the US House of Representatives passed the draft of the Biosecure Act, which aims to prohibit US pharma ...

Samsung Biologics will participate in major conventions across Europe and Asia, aiming to secure new contracts from global ...

Are you a fleet manager with questions that need answers before electrifying your fleet? Watch this 1-hour, interactive discussion, hosted by Pacific Gas and Electric Company (PG&E), Southern ...